278 related articles for article (PubMed ID: 23018969)
1. Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis.
de Greeff SC; de Melker HE; Westerhof A; Schellekens JF; Mooi FR; van Boven M
Epidemiology; 2012 Nov; 23(6):852-60. PubMed ID: 23018969
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the serial interval of pertussis in Dutch households.
Te Beest DE; Henderson D; van der Maas NA; de Greeff SC; Wallinga J; Mooi FR; van Boven M
Epidemics; 2014 Jun; 7():1-6. PubMed ID: 24928663
[TBL] [Abstract][Full Text] [Related]
3. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy.
Wiley KE; Zuo Y; Macartney KK; McIntyre PB
Vaccine; 2013 Jan; 31(4):618-25. PubMed ID: 23200883
[TBL] [Abstract][Full Text] [Related]
4. Pertussis disease burden in the household: how to protect young infants.
de Greeff SC; Mooi FR; Westerhof A; Verbakel JM; Peeters MF; Heuvelman CJ; Notermans DW; Elvers LH; Schellekens JF; de Melker HE
Clin Infect Dis; 2010 May; 50(10):1339-45. PubMed ID: 20370464
[TBL] [Abstract][Full Text] [Related]
5. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the spread of pertussis in households: a prospective study, Catalonia and Navarre, Spain, 2012 to 2013.
Godoy P; García-Cenoz M; Toledo D; Carmona G; Caylà JA; Alsedà M; Àlvarez J; Barrabeig I; Camps N; Plans P; Company M; Castilla J; Sala-Farré MR; Muñoz-Almagro C; Rius C; Domínguez À;
Euro Surveill; 2016 Nov; 21(45):. PubMed ID: 27918260
[TBL] [Abstract][Full Text] [Related]
7. The role of adults in household outbreaks of pertussis.
Baptista PN; Magalhães VS; Rodrigues LC
Int J Infect Dis; 2010 Feb; 14(2):e111-4. PubMed ID: 19559636
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies.
Lugnér AK; van der Maas N; van Boven M; Mooi FR; de Melker HE
Vaccine; 2013 Nov; 31(46):5392-7. PubMed ID: 24075918
[TBL] [Abstract][Full Text] [Related]
9. [Pertussis in the Netherlands].
de Greeff SC; de Melker HE; Mooi FR
Ned Tijdschr Geneeskd; 2010; 154():A1383. PubMed ID: 20170575
[TBL] [Abstract][Full Text] [Related]
10. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
van der Maas NA; Mooi FR; de Greeff SC; Berbers GA; Spaendonck MA; de Melker HE
Vaccine; 2013 Sep; 31(41):4541-7. PubMed ID: 23933365
[TBL] [Abstract][Full Text] [Related]
11. A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil.
Luz PM; Codeço CT; Werneck GL; Struchiner CJ
Epidemiol Infect; 2006 Aug; 134(4):850-62. PubMed ID: 16316489
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands.
Westra TA; de Vries R; Tamminga JJ; Sauboin CJ; Postma MJ
Clin Ther; 2010 Aug; 32(8):1479-95. PubMed ID: 20728761
[TBL] [Abstract][Full Text] [Related]
13. The impact of pre-school booster vaccination of 4--6-year-old children on pertussis in 0--1-year-old children.
Hviid A; Stellfeld M; Wohlfahrt J; Andersen PH; Melbye M
Vaccine; 2006 Feb; 24(9):1401-7. PubMed ID: 16207504
[TBL] [Abstract][Full Text] [Related]
14. A field study of household attack rates and the effectiveness of macrolide antibiotics in reducing household transmission of pertussis.
Terry JB; Flatley CJ; van den Berg DJ; Morgan GG; Trent M; Turahui JA; Greenwood MC; Corben PW; Bell GJ
Commun Dis Intell Q Rep; 2015 Mar; 39(1):E27-33. PubMed ID: 26063095
[TBL] [Abstract][Full Text] [Related]
15. Neonatal pertussis, cocooning and maternal immunization.
Swamy GK; Wheeler SM
Expert Rev Vaccines; 2014 Sep; 13(9):1107-14. PubMed ID: 25075629
[TBL] [Abstract][Full Text] [Related]
16. Community awareness and predictors of uptake of pertussis booster vaccine in South Australian adults.
Clarke M; Thomas N; Giles L; Marshall H
Vaccine; 2015 Dec; 33(51):7337-7343. PubMed ID: 26514422
[TBL] [Abstract][Full Text] [Related]
17. Pertussis in infants: preventing deaths and hospitalisations in the very young.
Wood N; Quinn HE; McIntyre P; Elliott E
J Paediatr Child Health; 2008 Apr; 44(4):161-5. PubMed ID: 18377367
[TBL] [Abstract][Full Text] [Related]
18. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1424-6. PubMed ID: 22012116
[TBL] [Abstract][Full Text] [Related]
19. [Source of infection in young infants hospitalized with Bordetella pertussis].
Perret C; Viviani T; Peña A; Abarca K; Ferrés M
Rev Med Chil; 2011 Apr; 139(4):448-54. PubMed ID: 21879182
[TBL] [Abstract][Full Text] [Related]
20. Pertussis-the case for universal vaccination.
Rittle C
J Spec Pediatr Nurs; 2010 Oct; 15(4):282-91. PubMed ID: 20880276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
